Clinical trial
Combination Chemotherapy in Treating Patients With Neurofibromatosis and…
NCT00030264 · Children's Hospital of Philadelphia, Other · Completed
Key facts
| NCT number | NCT00030264 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas |
| Official title | Vinblastine/Methotrexate For Severe Progressive Plexiform Neurofibromas: A Phase II Study |
| Lead sponsor | Children's Hospital of Philadelphia, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neurofibromatosis Type 1, Precancerous Condition |
| Intervention type | Drug |
| Interventions | Methotrexate, Vinblastine |
| Enrollment | 23 |
| Start date | Feb 1, 2001 |
| Primary completion | Dec 1, 2013 |
| Completion | Mar 1, 2016 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 8, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: